CFTR and cystic fibrosis: For this reason, the most effective pharmacological therapy of CF patients with F508del is represented by a combination of correctors and potentiators, which are required to rescue CFTR folding and trafficking to the plasma membrane, in addition to channel activity (Keating et al., 2018; Lopes‐Pacheco, 2020).